Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Clinical trial NCT00075894 · COMPLETED

Trial details

NCT number: NCT00075894
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2004-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.